2026年诺和诺德历年年报/社会责任报告/ESG报告合集（共29套打包）

1、Financial report for the period 1 January 2025 to 30 September 20255 November 2025Novo Nordisks sales increased by 12%in Danish kroner and by 15%at CER in the first nine months of 2025;R&D pipeli。

2、Novo Nordisk a focused healthcare companyInvestor presentationFirst nine months of 2025RAFAEL VALVERDERAFAEL VALVERDERafael lives with obesityMexico2Novo NordiskInvestor presentation First nine month。

3、Financial report for the period 1 January 2025 to 30 June 20256 August 2025 Novo Nordisks sales increased by 16%in Danish kroner and by 18%at constant exchange rates to DKK 154.9 billion in the first。

4、Annual Report 2023Novo Nordisk A/S Novo Alle 1,2880 Bagsvrd,Denmark CVR no.24256790 Juan Pablo Villaseor lives with obesity and cardiovascular disease.Until recently,Juan struggled with stigma and of。

5、1Investor presentation First six months of 2024Novo Nordisk a focused healthcare companyInvestor presentationFirst six months of 2024RAFAEL VALVERDERAFAEL VALVERDERafael lives with obesityMexicoABIGA。

6、Investor presentation First three months of 20241Novo Nordisk a focused healthcare companyInvestor presentationFirst three months of 2024RAFAEL VALVERDERAFAEL VALVERDERafael lives with obesityMexicoA。

7、1Investor presentation First nine months of 2024Novo Nordisk a focused healthcare companyInvestor presentationFirst nine months of 2024RAFAEL VALVERDERAFAEL VALVERDERafael lives with obesityMexicoABI。

8、Annual Report 2023Novo Nordisk A/S Novo Alle 1,2880 Bagsvrd,Denmark CVR no.24256790 Juan Pablo Villaseor lives with obesity and cardiovascular disease.Until recently,Juan struggled with stigma and of。

9、AnnualReport 2022Erik Hageman(far right)is one of Denmarks longest-living people with type 1 diabetes,pictured here with his son Lars,who also has type 1 diabetes,and his grandchildren(from the left)。

10、 Novo Nordisk Annual Report 2021Morten Kruse-Jacobsen(to the right),Senior Director at Novo Nordisk and married to Anders.Being a sustainable employer is a key priority for Novo Nordisk.This includes。

11、 Novo Nordisk Annual Report 2020Team Novo Nordisk,the worlds first all-diabetes professional cycling team,are racing with 100 on their jersey to celebrate the 100-year anniversary of the discovery of。

12、Novo NordiskAnnual Report 2019ROSHNI Roshni has type 1 diabetes and lives in IndiaManagement reviewIntroducing Novo Nordisk01 Letter from the Chair02 Letter from the CEO04 Novo Nordisk at a glance06 。

13、Partnering for innovationCommitted to making obesity a healthcare priorityThe future in a tabletNovo NordiskAnnual Report 2018Management reviewLettersLetter from the chair .01Letter from the CEO .02 。

14、novo nordiskANNUALREPORT2017A STRATEGY TODRIVE CHANGE FORPATIENTS LIVESRAISING THEINNOVATION HEIGHTGOOD DIABETESCARE REQUIRESMORE THAN BLOODGLUCOSE CONTROLWHY SOME PEOPLEWITH OBESITY NEEDMEDICAL TREA。

15、novo nordiskANNUAL REPORT2016DEFINING TIMES FOR THE US BUSINESSRISK MANAGEMENT Protecting long-term value creationA NEW ERA OF DIABETES TREATMENT?All references can be found on p 113.The Management r。

16、WHY DO SO MANY PEOPLE IN CITIES GET DIABETES?GLP-1 Small protein,big potential OBESITY How do you market a treatment for a disease that many doctors dont even acknowledge?GLOBAL DEMAND for diabetes p。

17、novo nordisk annual report2014CITIES NEED TO FIGHT DIABETES but how?THE STRUGGLE TO LOSE WEIGHT obesity is a major public health issueSTAY FOCUSED,THINK LONG-TERM Novo Nordisks business strategyA CUR。

18、 novo nordisk annual report 2013If Novo Nordisksbusiness strategywere to be describedin one word,it would haveto be focusThe one rule wehave to break the Rule of HalvesOne sizedoesnt fi t all when it。

19、 novo nordisk annual report 2012Sustainable growth can it be done?Insulin in a tablet why is it so difficult?Diabetes an emergency in slow motionStrategy is all about choiceNovo Nordisks performance 。

20、Fi nanci al,soci al and envi ronmental performanceKey figures201 1 2011 2010 ChangeFinancial performanceSales total DKK million 66,346 60,776 9.2%Diabetes care DKK million 50,425 45,710 10.3%of which。

21、Financial,social and environmental performanceKey fi gures2010 2010 2009 ChangeFinancial performanceSales total DKK million 60,776 51,078 19.0%Diabetes care DKK million 45,710 37,502 21.9%of which mo。

22、Creat i ng value t hrough i nnovat i onNovo Nordi sk A/S Annual Report 2009Fi nanci al,soci al and envi ronment al performancePerformancehi ghli ghts 2009 2009 2008 ChangeFi nanci al performanceSales。

23、Ph2 FSDOBGGSRRAOONECFLOOOORCNEWRCEEENSDCM*SNovo Nordisk A/S Annual Report 2008Financial,social and environmental performanceOur focus isour strengthPerformancehighlights2008 2008 2007 ChangeFinancial。

24、Novo Nordisk A/SAnnual Report 2007united to change diabetes financial,social and environmental performance 2007Performance highlights 200720072006ChangeFinancial performanceSales totalDKK million41,8。

25、action definesleadershipfinancial,social and environmental performance 2006diabetes care:sustainingleadershipbiopharmaceuticals:the portfolioexpandsBusinessresults re Biophuticals Challengingworkplac。

26、Corporate Governance Report 2023Novo Nordisk A/S Novo Alle 1,2880 Bagsvrd,Denmark CVR no.24256790 Juan Pablo Villaseor lives with obesity and cardiovascular disease.Until recently,Juan struggled with。

27、pursuingthe visionbusiness resultsdiabetes carebiopharmaceuticalschallenging workplacevalues in actionperformancehighlights consolidated financial and non-financial statements 2005 spotlight onaccess。

28、Statutory Corporate Governance Report for 2015cf.art.107b of the Danish Financial Statements ActSTATUTORY CORPORATE GOVERNANCE REPORT FOR 2015 2This Statutory Corporate Governance Report(hereinafter”。

29、ANNUAL REPORT 2004FINANCIAL,SOCIAL AND ENVIRONMENTAL PERFORMANCEREPORTIncluding financial and non-financialperformance data pages 41105Getting on with my lifeAdvances in insulin therapy make the diff。